Clinical Trial Update: Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

View source ↗

Summary

Completed cohort study evaluating the hepatic safety of Eviplera (rilpivirine/emtricitabine/tenofovir disoproxil fumarate) in HIV/HCV coinfected patients not tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Eviplera (rilpivirine/emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Fundación Pública Andaluza Progreso y Salud | Conditions: Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects | Status: COMPLETED